InsidersTradesSigma
Discover the full record of transactions filed by Tung Roger D, Chairman & CEO. Director active across 1 companies, notably Concert Pharmaceuticals, INC.. In total, 7 filings have been logged. Total volume traded: €37k. The latest transaction was filed on 15 February 2022 (Cession). Regulator: SEC (Form 4). All data is openly available.
7 of 7 declarations
Roger D. Tung is the Chief Executive Officer of Concert Pharmaceuticals, Inc. He leads the company in its efforts to develop innovative treatments. His leadership is essential for the strategy and growth of Concert Pharmaceuticals.